Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN
 

Outsourcing

Covid-19

COVID-19 is reshaping the pharmaceutical supply chain

The coronavirus pandemic may mark a rebalancing of where drugs are made as nations recognize a security imperative

by Rick Mullin
April 27, 2020 | A version of this story appeared in Volume 98, Issue 16
An illustration of a globe showing where active pharmaceutical ingredients are produced.

Credit: Will Ludwig/C&EN/Shutterstock

Article:

This article has been sent to the following recipient: